Treatment regimens for non-alcoholic fatty liver disease.
about
A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- miceThe amelioration of hepatic steatosis by thyroid hormone receptor agonists is insufficient to restore insulin sensitivity in ob/ob miceHepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case seriesMitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin.Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosisResveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expressionDocosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.Hepatoprotective effect of commercial herbal extracts on carbon tetrachloride-induced liver damage in Wistar rats.Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver diseaseA Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis.NCX 1000 Alone or in Combination with Vitamin E Reverses Experimental Nonalcoholic Steatohepatitis in the Rat Similarly to UDCA.Combination drug treatment in patients with non-alcoholic fatty liver disease.The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
P2860
Q27339224-4AD7EC9A-13B4-4C32-A03A-2EF9C3FA7CB2Q28545792-820BC65F-5AD6-471D-A410-22738561B432Q33816223-697027C0-3C61-4F49-AFAB-A91F55B42266Q34243380-1B32F396-869F-49B4-A30E-F387B591A097Q35009517-8983E398-67CD-4B01-AB7B-50EA35FF587CQ36656592-CBD56A86-CEF4-4873-A634-F40932EF2903Q37017917-6C16825D-EE98-4DB6-907B-E7A0A625A021Q37034996-7E98EA43-55BA-4897-A245-06EF21D0312BQ37196514-2668432D-3A9D-4A79-B4D4-F8DCDD2E2873Q37614028-A3D0FC7C-33A0-4CB9-9058-CC683F2AE057Q38733145-042F6C07-6E1D-4594-86B3-3B8E3F7DF46EQ41128646-01523CA3-0646-4364-9AAA-D25D9A8E37A9Q55222544-5DC2D935-219C-42DD-872E-71FAD9525BB9
P2860
Treatment regimens for non-alcoholic fatty liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment regimens for non-alcoholic fatty liver disease.
@en
Treatment regimens for non-alcoholic fatty liver disease.
@nl
type
label
Treatment regimens for non-alcoholic fatty liver disease.
@en
Treatment regimens for non-alcoholic fatty liver disease.
@nl
prefLabel
Treatment regimens for non-alcoholic fatty liver disease.
@en
Treatment regimens for non-alcoholic fatty liver disease.
@nl
P1476
Treatment regimens for non-alcoholic fatty liver disease
@en
P2093
Brian P Lam
Zobair M Younossi
P478
P577
2009-01-01T00:00:00Z